A Phase 2a, Multi-Center, Open-Label Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of PRA023 in Subjects with Moderately to Severely Active Crohn’s Disease

  • Leong, Rupert (Primary Chief Investigator)
  • Chapman, Nicola (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titlePR1200-103
AcronymAPOLLO-CD
StatusActive
Effective start/end date8/02/22 → 28/07/26